Eli Lilly and Company

Regional Market Access Manager Ontario & Atlantic

Canada

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in a relevant field, such as Pharmacy, Health Administration, or a related discipline, and have at least 5 years of experience in market access, pricing, or reimbursement within the pharmaceutical industry, with a strong focus on Canada. Experience working with provincial and federal drug plans, health technology assessments, and formulary listing processes is essential. Knowledge of Lilly’s therapeutic areas, particularly Oncology and Immunology, is highly desirable.

Responsibilities

The Regional Market Access Manager will be responsible for developing and maintaining relationships with priority payers and stakeholders within Ontario and the Atlantic provinces, including preparing and improving market access strategies for Lilly’s innovative products. This role involves collaborating with national PRA Head Office teams on HTA and provincial submissions, pCPA negotiations, and provincial listing agreements to ensure timely formulary listings with public payers. The RMAM will also support the Oncology and Immunology Innovation Readiness plans by partnering with various internal teams, and a key responsibility is to identify key decision-makers and influencers across multiple drug plans and cancer agencies to facilitate rapid access and reimbursement for new products.

Skills

Health Technology Assessments
Reimbursement Processes
Stakeholder Relationship Management
Account Planning
HTA
Provincial Reimbursement
Formulary Negotiations
Payer Engagement
Strategic Planning
Cross-functional Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI